Vision 2030 is the result of the merger between EverythingALS and Cure ALS—two foundations united by a common purpose. Together, we have harnessed our collective knowledge of the ALS and neurodegenerative research landscape to formulate a comprehensive strategy aimed at finding a cure and restoring lost function to people living with ALS. At the heart of our efforts is EverythingALS, a patient-focused non-profit organization led by Indu Navar. EverythingALS is pioneering the use of technology innovations, such as artificial intelligence and data science, to bridge the gap from care to cure for those affected by ALS.
A global, properly funded, and technology advantaged ecosystem that is united and focused on discovering the subtypes and root cause(s) of ALS.
Our mission is to accelerate the development of a cure for ALS by connecting researchers with the necessary data, technology, and partnerships to halt disease progression and promote nerve regeneration, restoring muscle strength and functionality for those affected.
The Vision 2030 consortium is a collaborative, global ecosystem, uniting researchers, pharmaceutical and biotech companies, academic institutions, hospital clinics, government agencies, and other private foundations dedicated to curing ALS and related neurodegenerative diseases.
We’re excited to welcome new partners to the Vision 2030 consortium and hope you’ll join our cause.
Indu, a seasoned entrepreneur, CEO, and investor, founded the Peter Cohen Foundation, operating as EverythingALS.org, a nonprofit fostering collaboration among ALS patients, researchers, and providers. With 20 years of experience in software companies, she led successful exits and M&A activities. As a former Managing Director at Woodside Capital Partners, Indu advised software firms on financing and M&A. She previously was CEO and founder of Serus Corporation, acquired by E2OPEN, and contributed to WebMD and Silicon Graphics. Her career began at NASA. Indu holds a B.S. in Electrical Engineering, an M.S. in Computer Science, and pursues a Ph.D. in Neuroscience.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
